Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × Everolimus × Clear all

NCT00096486 2016-01-21

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

Phase 1/2 Completed

74 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00406276 2013-08-23

Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer

Phase 1/2 Terminated

28 enrolled 7 charts

Lung Neoplasms